Search research articles
Contact Us
Filters
Showing results (171-180 of 183) with videos related to
Page
of 19
Sort By:
Future Science OA
|
July 14, 2021
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy
Matteo Ferro, Dragoş-Florin Babă, Ottavio de Cobelli, et al.
Future Oncology (London, England)
|
July 19, 2021
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy
Matteo Ferro, Giuseppe Lucarelli, Ottavio de Cobelli, et al.
World Journal of Urology
|
January 11, 2026
Real-world outcomes of bladder-sparing strategies for BCG-unresponsive non-muscle-invasive bladder cancer: a multicenter study
Pietro Scilipoti, Paolo Zaurito, Mattia Longoni, et al.
Urologic Oncology
|
December 13, 2024
Impact of smoking exposure on disease progression in high risk and very high-risk nonmuscle invasive bladder cancer patients undergoing BCG therapy
Roberto Contieri, Francesco Claps, Rodolfo Hurle, et al.
European Urology Oncology
|
June 17, 2022
Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer
Luca Afferi, Chiara Lonati, Francesco Montorsi, et al.
Minerva Urology and Nephrology
|
December 3, 2024
Assessing the influence of smoking on inflammatory markers in bacillus Calmette Guérin response among bladder cancer patients: a novel machine-learning approach
Matteo Ferro, Octavian S Tataru, Giuseppe Fallara, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 16, 2026
Surrogacy of Intermediate Clinical Endpoints for Overall Survival in Patients With Localized Muscle-Invasive Bladder Cancer
Pietro Scilipoti, Mario de Angelis, Constance Thibault, et al.
BJU International
|
June 25, 2025
Enhanced prognostic value of four-tier hybrid grading system in Ta non-muscle-invasive bladder cancer
Matteo Ferro, Michele Catellani, Roberto Bianchi, et al.
Cancers
|
November 13, 2021
The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort Analysis
Matteo Ferro, Francesco Del Giudice, Giuseppe Carrieri, et al.
Nature Reviews. Urology
|
April 1, 2026
Active surveillance in low-grade NMIBC - results of an international two-round modified Delphi consensus
Roberto Contieri, Paolo Gontero, Rodolfo Hurle, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 183) with videos related to
Sort By:
Page
of 19
Future Science OA
|
July 14, 2021
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy
Matteo Ferro, Dragoş-Florin Babă, Ottavio de Cobelli, et al.
Future Oncology (London, England)
|
July 19, 2021
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy
Matteo Ferro, Giuseppe Lucarelli, Ottavio de Cobelli, et al.
World Journal of Urology
|
January 11, 2026
Real-world outcomes of bladder-sparing strategies for BCG-unresponsive non-muscle-invasive bladder cancer: a multicenter study
Pietro Scilipoti, Paolo Zaurito, Mattia Longoni, et al.
Urologic Oncology
|
December 13, 2024
Impact of smoking exposure on disease progression in high risk and very high-risk nonmuscle invasive bladder cancer patients undergoing BCG therapy
Roberto Contieri, Francesco Claps, Rodolfo Hurle, et al.
European Urology Oncology
|
June 17, 2022
Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer
Luca Afferi, Chiara Lonati, Francesco Montorsi, et al.
Minerva Urology and Nephrology
|
December 3, 2024
Assessing the influence of smoking on inflammatory markers in bacillus Calmette Guérin response among bladder cancer patients: a novel machine-learning approach
Matteo Ferro, Octavian S Tataru, Giuseppe Fallara, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 16, 2026
Surrogacy of Intermediate Clinical Endpoints for Overall Survival in Patients With Localized Muscle-Invasive Bladder Cancer
Pietro Scilipoti, Mario de Angelis, Constance Thibault, et al.
BJU International
|
June 25, 2025
Enhanced prognostic value of four-tier hybrid grading system in Ta non-muscle-invasive bladder cancer
Matteo Ferro, Michele Catellani, Roberto Bianchi, et al.
Cancers
|
November 13, 2021
The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort Analysis
Matteo Ferro, Francesco Del Giudice, Giuseppe Carrieri, et al.
Nature Reviews. Urology
|
April 1, 2026
Active surveillance in low-grade NMIBC - results of an international two-round modified Delphi consensus
Roberto Contieri, Paolo Gontero, Rodolfo Hurle, et al.
Page
of 19